A systematic review of the role of bisphosphonates in metastatic disease.

Author: BroadleyK, EdmondsP M, NormandC, PatelS, RossJ R, SaundersY, WonderlingD

Paper Details 
Original Abstract of the Article :
To identify evidence for the role of bisphosphonates in malignancy for the treatment of hypercalcaemia, prevention of skeletal morbidity and use in the adjuvant setting. To perform an economic review of current literature and model the cost effectiveness of bisphosphonates in the treatment of hyperc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.3310/hta8040

データ提供:米国国立医学図書館(NLM)

Bisphosphonates: A Shield Against the Storm of Metastatic Disease

Cancer, a relentless disease that can spread throughout the body, can cause bone complications, such as hypercalcemia and skeletal morbidity. It's like a desert storm, sweeping across a camel caravan, damaging its members and disrupting their journey. Bisphosphonates, a class of drugs that help strengthen bones, have shown potential in managing these bone complications. This systematic review examines the role of bisphosphonates in metastatic disease, looking at their use in treating hypercalcemia, preventing skeletal morbidity, and their potential as an adjuvant therapy.

Bisphosphonates: A Potential Tool in the Fight Against Cancer

The systematic review highlights the potential benefits of bisphosphonates in managing bone complications associated with metastatic disease. Their use in treating hypercalcemia and preventing skeletal morbidity suggests a valuable role in improving the quality of life for cancer patients.

Bisphosphonates: A Beacon of Hope in the Desert of Cancer

This review underscores the importance of bisphosphonates in managing bone complications associated with metastatic disease. It offers hope for a more comfortable and manageable journey for cancer patients battling the debilitating effects of this disease. It's like finding a source of water in the desert, providing relief from the harsh conditions and a path towards a better outcome.

Dr. Camel's Conclusion

This systematic review highlights the importance of bisphosphonates in managing bone complications associated with metastatic disease. Their use offers a potential avenue for improving the quality of life for cancer patients.

Date :
  1. Date Completed 2004-05-13
  2. Date Revised 2019-11-08
Further Info :

Pubmed ID

14960258

DOI: Digital Object Identifier

10.3310/hta8040

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.